Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2006; 95(04): 752-754
DOI: 10.1160/TH05-10-0657
DOI: 10.1160/TH05-10-0657
Letters to the Editor
The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma
Authors
Further Information
Publication History
Received
06 October 2005
Accepted after resubmission
20 February 2006
Publication Date:
30 November 2017 (online)
-
References
- 1 Falanga A, Rickels FR. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost 1999; 25: 173-82.
- 2 Di Micco P, Romano M, Niglio A. et al. Alteration of haemostasis in non-metastatic gastric cancer. Dig Liver Dis 2001; 33: 546-50.
- 3 Otten HM, Mathijssen J, ten Cate H. et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy, an understimated phenomenon. Arch Intern Med 2004; 164: 190-4.
- 4 Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
- 5 Mandalà M, Curigliano G, Bucciarelli P. et al. FactorV Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol 2004; 15: 590-3.
- 6 Blom J, Doggen CJM, Osanto S. et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-22.
- 7 Levine MN, Gent M, Hirsh J. et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 1988; 318: 404-7.
- 8 von Tempelhoff GF, Dietrich M, Hommel G. et al. Blood coagulation during adjuvant epirubicin cyclophosphamide chemotherapy in patients with primary operable breast cancer. J Clin Oncol 1996; 14: 2560-8.
- 9 Sifontes MT, Nuss R, Hunger SP. et al. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 1997; 96: 484-9.
- 10 Rees D, Grimwade D, Langabeer S. et al. Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia. MRC Adult Leukaemia Working Party. Br J Haematol 1997; 96: 490-2.
- 11 Mitchell LG. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Cancer 2003; 97: 508-16.
- 12 Pihusch R, Danzl G, Scholz M. et al. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma. Cancer 2002; 94: 3120-6.